Selective inducible nitric oxide synthase inhibition in septic shock.
Beilman
G J
GJ
D000578:Amidines / Q000627:therapeutic use*; D000818:Animals; D004285:Dogs; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006574:Heterocyclic Compounds, 2-Ring / Q000627:therapeutic use*; D006801:Humans; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D052247:Nitric Oxide Synthase Type II; D012772:Shock, Septic / Q000188:drug therapy*
C407360:7-chloro-3-imino-5-methyl-2-azabicyclo(4.1.0)heptane; D000578:Amidines; D004791:Enzyme Inhibitors; D006574:Heterocyclic Compounds, 2-Ring; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II